Brokerages Set Select Medical Holdings Co. (NYSE:SEM) Target Price at $39.00

Shares of Select Medical Holdings Co. (NYSE:SEM) have received a consensus rating of “Moderate Buy” from the four ratings firms that are presently covering the company, MarketBeat reports. One analyst has rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $39.00.

A number of research firms have recently weighed in on SEM. Benchmark reaffirmed a “buy” rating and issued a $48.00 price target on shares of Select Medical in a research note on Friday, September 6th. Bank of America assumed coverage on shares of Select Medical in a report on Tuesday, August 20th. They issued a “buy” rating and a $42.00 target price on the stock.

Select Medical Price Performance

NYSE:SEM opened at $31.74 on Friday. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 2.11. The business’s 50-day moving average price is $34.35 and its 200 day moving average price is $33.83. Select Medical has a 52-week low of $21.28 and a 52-week high of $40.50. The firm has a market cap of $4.13 billion, a P/E ratio of 15.19, a PEG ratio of 2.03 and a beta of 1.41.

Select Medical (NYSE:SEM) last issued its quarterly earnings results on Thursday, August 1st. The health services provider reported $0.60 earnings per share for the quarter, missing analysts’ consensus estimates of $0.61 by ($0.01). The company had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.74 billion. Select Medical had a return on equity of 17.50% and a net margin of 3.91%. The company’s revenue for the quarter was up 5.1% compared to the same quarter last year. During the same period in the prior year, the business posted $0.61 EPS. As a group, sell-side analysts predict that Select Medical will post 2.03 earnings per share for the current fiscal year.

Select Medical Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Wednesday, August 14th were given a $0.125 dividend. The ex-dividend date of this dividend was Wednesday, August 14th. This represents a $0.50 annualized dividend and a yield of 1.58%. Select Medical’s dividend payout ratio (DPR) is currently 23.92%.

Institutional Trading of Select Medical

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its position in Select Medical by 2.9% in the fourth quarter. Vanguard Group Inc. now owns 12,347,798 shares of the health services provider’s stock valued at $290,173,000 after buying an additional 342,496 shares in the last quarter. Romano Brothers AND Company boosted its holdings in Select Medical by 2.6% during the first quarter. Romano Brothers AND Company now owns 78,400 shares of the health services provider’s stock worth $2,364,000 after buying an additional 2,000 shares during the last quarter. Allspring Global Investments Holdings LLC grew its holdings in Select Medical by 6.6% during the first quarter. Allspring Global Investments Holdings LLC now owns 6,563 shares of the health services provider’s stock valued at $198,000 after purchasing an additional 405 shares during the period. Denali Advisors LLC increased its position in shares of Select Medical by 96.7% in the 1st quarter. Denali Advisors LLC now owns 125,483 shares of the health services provider’s stock valued at $3,783,000 after buying an additional 61,700 shares in the last quarter. Finally, Principal Financial Group Inc. increased its holdings in shares of Select Medical by 4.5% in the first quarter. Principal Financial Group Inc. now owns 2,241,823 shares of the health services provider’s stock worth $67,591,000 after acquiring an additional 95,707 shares in the last quarter. Institutional investors own 89.48% of the company’s stock.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.